Related Experiment Video
Updated: May 26, 2026
10:04
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
[Research advances of multiple myeloma immunophenotyping]
Yan Pang1, Li Li, Li-Ping Kuang
1Department of Hematology, Guangzhou General Hospital, Guangdong Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|December 16, 2011
Summary
Multiple myeloma (MM) is a B-cell cancer. Immunotyping aids in diagnosing MM by examining bone marrow plasma cells and monoclonal immunoglobulin levels, crucial for prognosis.
Area of Science:
- Hematology
- Oncology
- Immunology
Context:
- Multiple myeloma (MM) is a malignant plasma cell disorder.
- MM is characterized by bone marrow infiltration, bone lesions, and excess monoclonal immunoglobulin production.
- Diagnosis involves bone marrow examination, immunoglobulin quantification, and assessment of organ damage.
Purpose:
- This review highlights the critical role of immunotyping in diagnosing multiple myeloma.
- It emphasizes immunotyping's significance for determining patient prognosis.
- The review aims to clarify immunotyping's utility in MM management.
Summary:
- Multiple myeloma involves malignant plasma cells (PC) accumulating in bone marrow.
- Diagnostic criteria include PC infiltration, monoclonal immunoglobulin detection (serum/urine), and organ damage indicators (e.g., hypercalcemia, renal insufficiency, anemia, bone lesions).
- Immunotyping is essential for accurate diagnosis and prognostic assessment in MM patients.
Impact:
- Enhanced understanding of immunotyping's diagnostic value in multiple myeloma.
- Improved prognostic accuracy through detailed immunotyping analysis.
- Provides a basis for tailored treatment strategies in MM based on immunophenotypic characteristics.
